Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Teva Enhances ADHD Product Line with Generic INTUNIV in the United States

JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced the launch of the generic equivalent to INTUNIV® (guanfacine) 1 mg, 2 mg, 3 mg, and 4 mg, in the United States. Guanfacine extended-release tablets are a nonstimulant medication for the treatment of attention deficit hyperactivity disorder (ADHD) that can be used alone, or as an add-on […]

Read More »

Par Specialty Pharmaceuticals Launches Cortisporin-TC Otic Suspension

CHESTNUT RIDGE, N.Y., May 26, 2015 /PRNewswire/ — Par Specialty Pharmaceuticals, a division of Par Pharmaceutical, Inc., today announced the launch of Cortisporin®-TC Otic Suspension (colistin sulfate – neomycin sulfate – thonzonium bromide – hydrocortisone acetate otic suspension).  Cortisporin®-TC Otic Suspension is indicated for the treatment of superficial bacterial infections of the external auditory canal (otitis […]

Read More »

Meridian Bioscience Europe Launches New Molecular Tests for the Detection of Herpes Simplex Virus Type 1 and Type 2

CINCINNATI–(BUSINESS WIRE)–Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that it has received the CE Mark for new molecular assays for the detection of Herpes Simplex Virus Type 1 (HSV-1) and Type 2 (HSV-2), to be run on its molecular platform, illumigene®. The HSV 1&2 assays are additions to the portfolio of molecular tests available for […]

Read More »

Biodesix Launches GeneStrat Targeted Liquid Biopsy Mutation Test For Patients With Advanced Lung Cancer

BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. today announced the launch of GeneStrat™, a targeted liquid biopsy mutation test for genotyping tumors of patients with advanced non-small cell lung cancer (NSCLC). The blood test results are available within 72 hours, providing physicians actionable diagnostic information prior to making treatment decisions. GeneStrat is focused exclusively on the clinically actionable […]

Read More »

America’s Most-Preferred Multivitamin Brand Launches New Centrum® MultiGummies

MADISON, N.J.–(BUSINESS WIRE)–Pfizer Consumer Healthcare, the makers of America’s most-preferred and most-clinically studied multivitamin brand, Centrum®, has announced the launch of Centrum® MultiGummies, a great-tasting, easy-to-take multivitamin, specifically designed with key nutrients to help support energy, immunity and metabolism. “According to nutritional health data, nine out of 10 Americans are not getting enough of key […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom